SC therapy can significantly reduce the expression levels of proinflammatory factors such as IL-6, IL-1, and TNF-α in the serum of patients with depression and upregulate anti-inflammatory factors to improve the brain inflammatory response. This evidence concerns the gene IL1B and depressive disorder.